GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results presented at ASCO Gastrointestinal Cancers Symposium. Among 8- to 9-year-olds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback